Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  ResApp Health Limited    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 11/26
0.09 AUD   -1.10%
04/05RESAPP HEALTH : Morgans rates RAP as Add
AQ
2019RESAPP HEALTH : 2019 Letter to Shareholders
PU
2017RESAPP HEALTH : Updated Corporate Governance Policies
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about RESAPP HEALTH LIMITED
04/05RESAPP HEALTH : Morgans rates RAP as Add
AQ
2019RESAPP HEALTH : 2019 Letter to Shareholders
PU
2017RESAPP HEALTH : Updated Corporate Governance Policies
PU
2017RESAPP HEALTH (ASX : RAP) talks study results and clinical trials
FI
2017RESAPP HEALTH : Update on Field Evaluation by Médecins Sans Frontières/Doctors W..
PU
2017RESAPP HEALTH : Update on Field Evaluation by Medecins Sans Frontieres
PU
2017RESAPP HEALTH : SMARTCOUGH-C Study and Paediatric Clinical Strategy Update
PU
2017RESAPP HEALTH : Appendix 4E - Preliminary Final Report
PU
2017RESAPP HEALTH : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTH : Dr Philip Currie Joins ResApp's Scientific Advisory Board
PU
2017RESAPP HEALTH : Receives R&D Tax Incentive Cash Refund for FY16
PU
2017RESAPP HEALTH : Reports Preliminary Top-line Results from SMARTCOUGH-C Study for..
PU
2017RESAPP HEALTH : Change of Director's Interest Notice
PU
2017RESAPP HEALTH : Investor Conference Call
PU
2017RESAPP HEALTH : Appendix 4C - Quarterly Jun 2017
PU
2017RESAPP HEALTH : Investor Presentation
PU
2017RESAPP HEALTH : Morgans Initiates Research Coverage
PU
2017RESAPP HEALTH : Release of Restricted Securities
PU
2017RESAPP HEALTH : Announces Completion of Enrolment in SMARTCOUGH-C Study
PU
2017RESAPP HEALTH : Completion of Enrolment in SMARTCOUGH-C Study
PU
2017RESAPP HEALTH : Presentation at ASX Spotlight Investor Conference
PU
2017RESAPP HEALTH : Provides SMARTCOUGH-C May Study Update
PU
2017RESAPP HEALTH : ResAppDx to be Formally Evaluated by Médecins Sans Frontières/Do..
PU
2017RESAPP HEALTH : ResAppDx to be Formally Evaluated by Doctors Without Borders
PU
2017RESAPP HEALTH : Extension of CEO and Managing Director's Contract
PU
2017RESAPP HEALTH : Licenses Additional Pneumonia Diagnostic Tool from UniQuest
PU
2017RESAPP HEALTH : Appendix 4C - Quarterly Mar 2017
PU
2017LNK : Change of Perth Address for Shareholder Purposes
PU
2017RESAPP HEALTH : Extends SMARTCOUGH-C Study
PU
2017RESAPP HEALTH : to Present at Upcoming Conferences in March
PU
2017RESAPP HEALTH (ASX : RAP) discusses revolutionary diagnostic app for respiratory..
FI
2017RESAPP HEALTH : Appendix 3B
PU
2017RESAPP HEALTH : Appendix 4C - Quarterly Dec 2016
PU
2017RESAPP HEALTH : Announces Expanded Research Collaboration with MGH
PU
2017RESAPP HEALTH : Announces Expanded Research Collaboration with Massachusetts Gen..
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Patersons Securities Initiates Research Coverage
PU
2016RESAPP HEALTH : Receives Institutional Review Board Approval at Texas Children's..
PU
2016RESAPP HEALTH : Receives Institutional Review Board Approval at Massachusetts Ge..
PU
2016RESAPP HEALTH : Change of Director's Interest Notice x 4
PU
2016RESAPP HEALTH : Appendix 3B
PU
2016RESAPP HEALTH : Receives IRB Approval at Massachusetts General
PU
2016RESAPP HEALTH : Confirmation of Change of Auditor
PU
2016RESAPP HEALTH : Appendix 4C - Quarterly Sep 2016
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Receives First Institutional Review Board Approval for SMARTCOUG..
PU
2016RESAPP HEALTH : Receives First Institutional Review Board Approval
PU
2016RESAPP HEALTH : Investor Presentation
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Announces Further Positive Results from Adult Clinical Study
PU
2016RESAPP HEALTH : Further Positive Results From Adult Clinical Study
PU
2016RESAPP HEALTH : Appendix 3B & Section 708A Notice
PU
2016RESAPP HEALTH : Change in substantial holding
PU
2016RESAPP HEALTH : Change of Auditor
PU
2016RESAPP HEALTH : Appendix 4C - Quarterly Jun 2016
PU
2016RESAPP HEALTH : Bioshares Biotech Summit Presentation
PU
2016RESAPP HEALTH : Appendix 3B
PU
2016RESAPP HEALTH : Update on US Clinical Study
PU
2016RESAPP HEALTH : Positive Preliminary Results from Adult Clinical Study
PU
2016RESAPP HEALTH : Release of Restricted Securities
PU
2016RESAPP HEALTH : Appendix 3B
PU
2016RESAPP HEALTH : Provides Australian Adult Study Enrolment Update
PU
2016RESAPP HEALTH : Appendix 3B - Exercise of Options
PU
2016RESAPP HEALTH : Appendix 3B - Release of Restricted Securities
PU
2016RESAPP HEALTH : Investor Presentation
PU
2016RESAPP HEALTH : Appendix 4C - Quarterly Mar 2016
PU
2016RESAPP HEALTH : Appendix 3B and Issue of Cleansing Prospectus
PU
2016RESAPP HEALTH : Completes Oversubscribed $12.5 Million Capital Raising to Expand..
PU
2016RESAPP HEALTH : Completes Oversubscribed $12.5M Capital Raising
PU
2016RESAPP HEALTH : Provides Updated Paediatric Clinical Study Results
PU
2016RESAPP HEALTH : Director Resignation and Appendix 3Z
PU
2016RESAPP HEALTH : talks development of digital healthcare solutions
FI
2016RESAPP HEALTH : Change of Director's Interest Notice
PU
2016RESAPP HEALTH : Presentation at the ASX CEO Sessions
PU
2016RESAPP HEALTH : Terms of Executive Appointment
PU
1  2Next
Upcoming event on RESAPP HEALTH LIMITED